Sirolimus for Pediatric Cervicofacial Lymphatic Malformation : A Systematic Review and Meta-Analysis
© 2023 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc..
OBJECTIVE: This study is a systematic review and meta-analysis of the efficacy and safety of sirolimus in the management of pediatric cervicofacial lymphatic malformations (LMs).
DATA SOURCES: EMBASE, Medline, Scopus, and Cochrane databases were searched, along with the reference list of all included articles.
REVIEW METHODS: The study protocol was registered with PROSPERO and a systematic literature search strategy was designed and conducted with the aid of a medical librarian. All studies including case reports were included, with pooled analysis of raw data. A meta-analysis was conducted of magnetic resonance imaging (MRI), clinical, and airway outcomes.
RESULTS: Thirteen case series and five individual case reports were included. Meta-analysis showed 78% (95% CI 57%-94%) of 62 patients had a reduction in LM volume, on MRI criteria, by 20% or more, and 32% (95% CI 11%-57%) had a reduction of 50% or more. Further meta-analysis showed 97% (95% CI 88%-100%) of 78 patients reported some clinical improvement on sirolimus. Sirolimus may be of particular value in management of airway LMs; out of 27 tracheostomy-dependent patients, meta-analysis showed 33% (95% CI 1%-78%) were decannulated after starting sirolimus. Individual patient meta-analysis on 24 individuals showed a statistically significant better response to sirolimus when initiated under the age of 2 years.
CONCLUSION: This review and meta-analysis support the efficacy of sirolimus in pediatric LMs of the head, neck, and airway. A large multi-center trial is needed to further explore its role and limitations. Laryngoscope, 134:2038-2047, 2024.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:134 |
---|---|
Enthalten in: |
The Laryngoscope - 134(2024), 5 vom: 29. Apr., Seite 2038-2047 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kamhieh, Yasmine [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cystic hygroma |
---|
Anmerkungen: |
Date Completed 11.04.2024 Date Revised 11.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/lary.31091 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363053441 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM363053441 | ||
003 | DE-627 | ||
005 | 20240411232124.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/lary.31091 |2 doi | |
028 | 5 | 2 | |a pubmed24n1372.xml |
035 | |a (DE-627)NLM363053441 | ||
035 | |a (NLM)37812168 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kamhieh, Yasmine |e verfasserin |4 aut | |
245 | 1 | 0 | |a Sirolimus for Pediatric Cervicofacial Lymphatic Malformation |b A Systematic Review and Meta-Analysis |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.04.2024 | ||
500 | |a Date Revised 11.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc. | ||
520 | |a OBJECTIVE: This study is a systematic review and meta-analysis of the efficacy and safety of sirolimus in the management of pediatric cervicofacial lymphatic malformations (LMs) | ||
520 | |a DATA SOURCES: EMBASE, Medline, Scopus, and Cochrane databases were searched, along with the reference list of all included articles | ||
520 | |a REVIEW METHODS: The study protocol was registered with PROSPERO and a systematic literature search strategy was designed and conducted with the aid of a medical librarian. All studies including case reports were included, with pooled analysis of raw data. A meta-analysis was conducted of magnetic resonance imaging (MRI), clinical, and airway outcomes | ||
520 | |a RESULTS: Thirteen case series and five individual case reports were included. Meta-analysis showed 78% (95% CI 57%-94%) of 62 patients had a reduction in LM volume, on MRI criteria, by 20% or more, and 32% (95% CI 11%-57%) had a reduction of 50% or more. Further meta-analysis showed 97% (95% CI 88%-100%) of 78 patients reported some clinical improvement on sirolimus. Sirolimus may be of particular value in management of airway LMs; out of 27 tracheostomy-dependent patients, meta-analysis showed 33% (95% CI 1%-78%) were decannulated after starting sirolimus. Individual patient meta-analysis on 24 individuals showed a statistically significant better response to sirolimus when initiated under the age of 2 years | ||
520 | |a CONCLUSION: This review and meta-analysis support the efficacy of sirolimus in pediatric LMs of the head, neck, and airway. A large multi-center trial is needed to further explore its role and limitations. Laryngoscope, 134:2038-2047, 2024 | ||
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a cystic hygroma | |
650 | 4 | |a lymphatic malformations | |
650 | 4 | |a pediatric | |
650 | 4 | |a rapamycin | |
650 | 4 | |a sirolimus | |
650 | 4 | |a tracheostomy | |
650 | 7 | |a Sirolimus |2 NLM | |
650 | 7 | |a W36ZG6FT64 |2 NLM | |
700 | 1 | |a Mitra, Robin |e verfasserin |4 aut | |
700 | 1 | |a Burnett, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Jones, Hugh |e verfasserin |4 aut | |
700 | 1 | |a Roblin, Graham |e verfasserin |4 aut | |
700 | 1 | |a Hall, Andrew |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Laryngoscope |d 1945 |g 134(2024), 5 vom: 29. Apr., Seite 2038-2047 |w (DE-627)NLM000205370 |x 1531-4995 |7 nnns |
773 | 1 | 8 | |g volume:134 |g year:2024 |g number:5 |g day:29 |g month:04 |g pages:2038-2047 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/lary.31091 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 134 |j 2024 |e 5 |b 29 |c 04 |h 2038-2047 |